Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Josh Allen, Raquel Romay-Tallón, Kyle J. Brymer, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 276

Showing 1-25 of 276 citing articles:

Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
Ruozhi Dang, Mingyang Wang, Xinhui Li, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 286
Oxidative eustress: On constant alert for redox homeostasis
Helmut Sies
Redox Biology (2021) Vol. 41, pp. 101867-101867
Open Access | Times Cited: 222
Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior
Iva Lukić, Dmitriy Getselter, Ziv Oren, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Mitophagy in Human Diseases
Laura Doblado, Claudia Lueck, Claudia Rey, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3903-3903
Open Access | Times Cited: 163
Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: Does inflammation play a role?
Giselli Scaini, Brittany L. Mason, Alexandre Paim Díaz, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1095-1102
Closed Access | Times Cited: 106
Anti-Inflammatory, Antioxidant, and Neuroprotective Effects of Polyphenols—Polyphenols as an Element of Diet Therapy in Depressive Disorders
Anna Winiarska‐Mieczan, Małgorzata Kwiecień, Karolina Jachimowicz-Rogowska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2258-2258
Open Access | Times Cited: 50
Major Depressive Disorder and Oxidative Stress: A Review of Peripheral and Genetic Biomarkers According to Clinical Characteristics and Disease Stages
Abd El Kader Ait Tayeb, Vianney Poinsignon, Kenneth Chappell, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 942-942
Open Access | Times Cited: 45
Unravelling the complexities of depression with medical intelligence: exploring the interplay of genetics, hormones, and brain function
Md Belal Bin Heyat, Faijan Akhtar, Farwa Munir, et al.
Complex & Intelligent Systems (2024) Vol. 10, Iss. 4, pp. 5883-5915
Open Access | Times Cited: 19
Sexual Dimorphism in Migraine. Focus on Mitochondria
Michał Fila, Łukasz Przysło, Marcin Derwich, et al.
Current Pain and Headache Reports (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 2
Serotonin regulates mitochondrial biogenesis and function in rodent cortical neurons via the 5-HT2Areceptor and SIRT1–PGC-1α axis
Sashaina E. Fanibunda, Sukrita Deb, Babukrishna Maniyadath, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 22, pp. 11028-11037
Open Access | Times Cited: 136
Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism
Weiqi Hong, Fei Mo, Ziqi Zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 135
The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
Esmé Jansen van Vuren, Stephan F. Steyn, C. Brink, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 135, pp. 111200-111200
Open Access | Times Cited: 96
The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
Anna Giménez‐Palomo, Seetal Dodd, Gerard Anmella, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 93
Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation
Luodan Yang, Hannah Youngblood, Chongyun Wu, et al.
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 92
Hippocampal proteomic changes of susceptibility and resilience to depression or anxiety in a rat model of chronic mild stress
Min Tang, Haojun Huang, Shuiming Li, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 90
Mitochondria, Microglia, and the Immune System—How Are They Linked in Affective Disorders?
Carsten Culmsee, Susanne Michels, Stefanie Scheu, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 86
REM sleep’s unique associations with corticosterone regulation, apoptotic pathways, and behavior in chronic stress in mice
Mathieu Nollet, Harriet Hicks, Andrew McCarthy, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 7, pp. 2733-2742
Open Access | Times Cited: 77
Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus
Ahad Banagozar Mohammadi, Mohammadali Torbati, Fereshteh Farajdokht, et al.
Brain Research (2019) Vol. 1715, pp. 47-56
Closed Access | Times Cited: 76
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Maria S. Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110391-110391
Open Access | Times Cited: 70
Sex differences in the genetic architecture of depression
Hee‐Ju Kang, Yoomi Park, Kyung-Hun Yoo, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 69
Nrf2: An all-rounder in depression
Chengchao Zuo, Huấn Cao, Yu Song, et al.
Redox Biology (2022) Vol. 58, pp. 102522-102522
Open Access | Times Cited: 65
Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Gerwyn Morris, Adam J. Walker, Ken Walder, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 5, pp. 2158-2182
Closed Access | Times Cited: 61
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia
Inès Khadimallah, Raoul Jenni, Jan-Harry Cabungcal, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 2, pp. 1192-1204
Open Access | Times Cited: 59
Animal models for the study of depressive disorder
Juhyun Song, Young‐Kook Kim
CNS Neuroscience & Therapeutics (2021) Vol. 27, Iss. 6, pp. 633-642
Open Access | Times Cited: 58
A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders
Surabhi Thapliyal, Tanveer Singh, Shailendra Handu, et al.
Neurochemical Research (2021) Vol. 46, Iss. 5, pp. 1043-1057
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top